Help us: Donate
Follow us on:
×

Menu

Back

Tag: Policy

Aging timeline
Using Peter Pan, Wolverine, and a powerful economic model, a trio of prominent scientists argues that slowing aging can bring gargantuan economic benefits – an order of magnitude bigger than previously thought [1]. The marriage of economics and geroscience The paper, published in Nature Aging, looks rather unusual. It is co-authored by one of the...
Nir Barzilai Interview about metformin and longevity.
Dr. Nir Barzilai is one of the leading experts in geroscience, with more than 25 years of longevity research under his belt. He is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the author of the book Age Later. He is also the leading researcher of TAME,...
Mikhail Batin from Openlongevity
The life extension community has a number of long serving people in its ranks, and one of the longest-active of those in Russia is Mikhail Batin. His activities go way back to 2008 when the non-profit organization Science for Life Extension Foundation, which was first created with the mission to support scientific research to develop...
Elderly crowd
By the year 2050, one in four Europeans will be aged 65 or over, which presents a number of challenges and possible opportunities for Europe’s rapidly aging society. To this end, the European Commission published the "Green paper on ageing - Fostering solidarity and responsibility between generations" back in January to encourage a broad policy...
Elderly people road sign
The UK All Party Parliamentary Group for Longevity (APPG) launched the Levelling Up Health initiative recently. The initiative aims to close the life expectancy gap, address health inequality in the UK, and foster a preventative approach to healthcare to support healthy longevity. It is estimated that health inequality between the economically poorer north and the...
The senate building.
The good news is that the United States Senate has a Special Committee on Aging. The bad news is that it has little to do with the actual processes of aging and has not meaningfully furthered the research necessary to develop medical treatments for aging itself. Instead, the committee focuses its work on other issues...